Non-coding RNAs and epigenetic mechanisms in vascular remodeling
Vorsitz: D. G. Sedding (Hannover), T. Thum (Hannover)
| 13:30 | (V19) | Therapeutic potential of modulating non-coding RNAs in atherosclerotic plaques |
| L. Maegdefessel (Stockholm, SE) | ||
| 13:45 | Discussion | |
| 13:50 | (V20) | Vascular importance of the miR212/132 cluster |
| R. Kumarswamy (Hannover) | ||
| 14:05 | Discussion | |
| 14:10 | (V21) | Selective inhibition of BET bromodomains as therapeutic option to prevent negative vascular remodeling |
| S. Weisheit (Hannover) | ||
| 14:25 | Discussion | |
| 14:30 | (V22) | Non-coding RNAs in endothelial cell function |
| R. A. Boon (Frankfurt am Main) | ||
| 14:45 | Discussion | |
| 14:50 | (V23) | Final discussion |
| T. Thum (Hannover) | ||
| Im Anschluss: Mitgliederversammlung und Wahlen der AG4 |
